Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25141108 | 1.00 | PSMB5 (0.67) | PSMB5PSMB8 | |
| SCHEMBL25141149 | 0.89 | PSMB5 (0.68) | PSMB5PSMB8 | |
| SCHEMBL25141144 | 0.89 | PSMB5 (0.68) | PSMB5PSMB8 | |
| SCHEMBL25141217 | 0.88 | PSMB5 (0.60) | PSMB5PSMB8 | |
| SCHEMBL25141221 | 0.88 | PSMB5 (0.60) | PSMB5PSMB8 | |
| SCHEMBL29236418 | 0.87 | PSMB5 (0.58) | PSMB5PSMB8 | |
| SCHEMBL31107849 | 0.87 | PSMB5 (0.58) | PSMB5PSMB8 | |
| SCHEMBL25141210 | 0.87 | PSMB5 (0.58) | PSMB5PSMB8 | |
| SCHEMBL25141025 | 0.85 | PSMB5 (0.57) | PSMB5PSMB8 | |
| SCHEMBL31107817 | 0.85 | PSMB5 (0.57) | PSMB5PSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425529-A1 | BORIC ACID DERIVATIVE | Shouyao Holdings (beijing) Co., Ltd. (CN) | 2024-12-26 | — | — | US | disclosed |
| EP-4417614-A1 | BORONIC ACID DERIVATIVE | Shouyao Holdings (Beijing) Co., Ltd. (CN) | 2024-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425529-A1 | BORIC ACID DERIVATIVE | PSMA7, BRD7, PSMB7 | PSMB5 159/4885PSMB8 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.